This is a population that has not gotten a lot of attention, said an expert. Upgrading their pacemakers to a cardiac resynchronization device may be the answer for some.
They might offer fewer meaningful survival gains in patients on the four pillars of HFrEF med therapy, given the drug combo s prowess at cutting mortality, researchers speculate from their study.